Analysts Offer Predictions for CME Group FY2025 Earnings

CME Group Inc. (NASDAQ:CME - Free Report) - Zacks Research boosted their FY2025 earnings per share (EPS) estimates for CME Group in a research report issued to clients and investors on Thursday, April 10th. Zacks Research analyst T. De now expects that the financial services provider will post earnings per share of $10.50 for the year, up from their previous forecast of $10.40. The consensus estimate for CME Group's current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group's FY2026 earnings at $10.98 EPS and FY2027 earnings at $11.67 EPS.

Several other brokerages also recently weighed in on CME. Morgan Stanley raised CME Group from an "equal weight" rating to an "overweight" rating and set a $301.00 target price for the company in a research note on Tuesday, April 8th. Piper Sandler boosted their price objective on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods lifted their price target on CME Group from $256.00 to $257.00 and gave the stock a "market perform" rating in a research note on Friday, February 14th. Bank of America raised their price objective on CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Finally, Oppenheimer increased their target price on shares of CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research report on Friday, April 11th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, CME Group has an average rating of "Hold" and an average target price of $247.47.

Remove Ads

CME Group Price Performance

Shares of CME Group stock traded up $0.21 on Friday, hitting $263.08. The company's stock had a trading volume of 699,009 shares, compared to its average volume of 2,395,183. The company has a market capitalization of $94.80 billion, a price-to-earnings ratio of 27.21, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. CME Group has a 1 year low of $190.70 and a 1 year high of $273.42. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The firm has a fifty day moving average price of $256.03 and a 200-day moving average price of $239.72.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. This is an increase from CME Group's previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. CME Group's payout ratio is 51.71%.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 11,592 shares of the company's stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares of the company's stock, valued at $5,686,980. The trade was a 31.37 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,076 shares of company stock valued at $6,871,496 over the last quarter. 0.30% of the stock is owned by company insiders.

Institutional Trading of CME Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Albert D Mason Inc. purchased a new stake in shares of CME Group during the 1st quarter worth approximately $1,585,000. NorthCrest Asset Manangement LLC grew its position in shares of CME Group by 14.1% during the first quarter. NorthCrest Asset Manangement LLC now owns 12,717 shares of the financial services provider's stock worth $3,374,000 after acquiring an additional 1,570 shares during the last quarter. Davis Investment Partners LLC purchased a new stake in CME Group in the 1st quarter valued at $921,000. Net Worth Advisory Group grew its position in CME Group by 2.4% during the 1st quarter. Net Worth Advisory Group now owns 2,970 shares of the financial services provider's stock worth $788,000 after purchasing an additional 71 shares during the last quarter. Finally, First United Bank & Trust boosted its stake in shares of CME Group by 13.3% during the first quarter. First United Bank & Trust now owns 3,972 shares of the financial services provider's stock worth $1,054,000 after buying an additional 467 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.